Search Results | Clinicalinfo

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2481 – 2500 of 3231

Table 5. Significant Drug Interactions for Drugs Used to Treat or Prevent Opportunistic Infections

https://clinicalinfo.hiv.gov/node/9251

Laboratory Testing: Plasma HIV-1 RNA (Viral Load) and CD4 Count Monitoring

https://clinicalinfo.hiv.gov/node/9252

https://clinicalinfo.hiv.gov/node/9253

Long-Term Follow-Up of Infants Exposed to Antiretroviral Drugs

https://clinicalinfo.hiv.gov/node/9254

Financial Disclosure

https://clinicalinfo.hiv.gov/node/9255

Protease Inhibitors

https://clinicalinfo.hiv.gov/node/9256

Lopinavir/Ritonavir (Kaletra, LPV/r)

https://clinicalinfo.hiv.gov/node/9257

Darunavir (Prezista, DRV)

https://clinicalinfo.hiv.gov/node/9260

Initial Evaluation and Continued Monitoring of HIV During Pregnancy

https://clinicalinfo.hiv.gov/node/9261

Appendix C: Antiretroviral Counseling Guide for Health Care Providers

https://clinicalinfo.hiv.gov/node/9262

Hepatitis C Virus Infection

https://clinicalinfo.hiv.gov/node/9265

Intrapartum HIV Care

https://clinicalinfo.hiv.gov/node/9266

Cobicistat (Tybost, COBI)

https://clinicalinfo.hiv.gov/node/9267

https://clinicalinfo.hiv.gov/node/9268

Insulin Resistance, Asymptomatic Hyperglycemia, Diabetes Mellitus

https://clinicalinfo.hiv.gov/node/9270

https://clinicalinfo.hiv.gov/node/9271

Integrase Inhibitors

https://clinicalinfo.hiv.gov/node/9272

Pneumocystis Pneumonia

https://clinicalinfo.hiv.gov/node/9273

https://clinicalinfo.hiv.gov/node/9274

Central Nervous System Toxicity

https://clinicalinfo.hiv.gov/node/9276